Clareon Intraocular Lenses for Cataract

This trial tests two types of intraocular lenses (IOLs) for individuals undergoing cataract surgery. The researchers aim to compare the Clareon TruPlus lens with the Clareon monofocal lens to determine which one better improves vision post-surgery. Participants must have cataracts in both eyes that significantly impair vision and be scheduled for cataract surgery. This study suits those interested in exploring new lens options that could enhance eyesight. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, providing participants an opportunity to benefit from well-established options.

Research has shown that Clareon TruPlus Monofocal Intraocular Lenses (IOLs) are safe for cataract surgery. Studies have found that patients tolerate these lenses well, and they improve vision by replacing the eye's cloudy lens, a common issue in cataracts. Notably, these lenses do not exhibit glistening (tiny water droplets inside the lens), enhancing their safety and effectiveness.

Additionally, Clareon monofocal IOLs, also included in this trial, have undergone long-term studies without major safety concerns. These studies demonstrate that the lenses remain clear and stable over time, providing good vision without significant side effects.

Researchers are excited about the Clareon Intraocular Lenses (IOLs) for cataracts because they offer advanced options over traditional lenses like acrylic or silicone-based IOLs. The Clareon TruPlus lens is particularly promising due to its enhanced optical clarity and reduced risk of photic phenomena, which can cause visual disturbances like halos or glares. Additionally, the Clareon monofocal lens provides improved visual outcomes with a focus on crisp distance vision. These features provide potential for better vision quality and a more comfortable post-surgery experience for patients.

This trial will compare Clareon TruPlus intraocular lenses (IOLs) with Clareon monofocal lenses for people with cataracts. Studies have shown that Clareon IOLs provide excellent vision. Specifically, Clareon TruPlus IOLs, which participants in this trial may receive, improve vision by about 3.5 letters at certain distances compared to standard Clareon lenses. Long-term results indicate that these lenses offer stable and clear vision, with a low risk of cloudiness developing after surgery and no issues with tiny sparkling spots. Both Clareon TruPlus and standard lenses are effective and safe, providing good vision over time. These lenses replace the eye's natural lens damaged by cataracts, helping patients see more clearly.¹⁴⁵⁶⁷